What is XTXXF's health score?

Adastra Holdings Ltd. (XTXXF) has a TradeApes health score of 57 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is XTXXF's estimated fair value?

Based on our 5-year discounted cash flow model, Adastra Holdings Ltd.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is XTXXF undervalued or overvalued?

Our model currently rates XTXXF as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

2 free score cards remaining

Adastra Holdings Ltd. (XTXXF)

Healthcare Inconclusive inconclusive mixed

$0.01

Updated: 2026-07-15

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

65 Healthy

Relative Value

65 Healthy

Capital Allocation

35 Weak

Risk Management

70 Healthy

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Industry Related Stocks

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH) AbbVie Inc. (ABBV) AbCellera Biologics Inc. (ABCL)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.